Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of HIV Vaccine 732462 in ART-naïve HIV-1 Infected Persons

NCT01218113 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01218113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01218113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of HIV Vaccine 732462 in ART-naïve HIV-1 Infected Persons
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 8, 2010
Completion date
November 5, 2012
Enrollment
191 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

aids